VIGIL NEUROSCIENCE, INC.

Insiders Vigil Neuroscience, Inc.

Equities

VIGL

US92673K1088

Market Closed - Nasdaq Other stock markets 01:30:00 16/05/2024 am IST			5-day change	1st Jan Change
3.485 ^USD	-4.78%		-7.80%	+3.11%

07/05	Vigil Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
17/04	Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vigil Neuroscience Names Petra Kaufmann Chief Medical Officer	20/03	MT
Vigil Neuroscience, Inc. Announces Executive Changes	20/03	CI
Vigil Neuroscience, Inc. Appoints Christopher J. Silber, M.D. as Chief Medical Officer	08/23/08	CI
Vigil Neuroscience Names Christopher Silber Chief Medical Officer	08/23/08	MT
Vigil Neuroscience, Inc. Appoints Samantha Budd Haeberlein to Its Board of Directors	09/23/09	CI
Vigil Neuroscience, Inc. Announces Resignation of Shaan Gandhi, from Member of Board of Directors	11/23/11	CI
Bionomics Appoints Spyridon Papapetropoulos President, CEO	16/22/16	MT
Bionomics Appoints President/CEO; Shares Climb 10%	16/22/16	MT
Vigil Neuroscience, Inc. Announces Executive Changes	16/22/16	CI
Vigil Neuroscience Appoints Suzanne Bruhn to Its Board of Directors	28/22/28	CI
Vigil Neuroscience, Inc. Appoints Christopher Verni as General Counsel and Mary Thistle to Its Board of Directors	20/22/20	CI
Insider Buy: Vigil Neuroscience	12/22/12	MT
Insider Buy: Vigil Neuroscience	12/22/12	MT
Insider Buy: Vigil Neuroscience	12/22/12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW